Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-08 | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY
(Chief Medical Officer) |
M | Common Stock | A | 7345 | $77.81 - $102.90 | $599,871 |
| 2024-11-04 | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A
(Director) |
G | Common Stock | D | 2000 | $0.00 - $0.00 | $0 |
| 2024-08-13 | NEUROCRINE BIOSCIENCES INC | LYONS GARY A
(Director) |
S | Common Stock | D | 11570 | $150.43 - $150.43 | $1,740,449 |
| 2024-08-13 | NEUROCRINE BIOSCIENCES INC | LYONS GARY A
(Director) |
M | Common Stock | A | 11570 | $42.76 - $42.76 | $494,733 |
| 2024-08-13 | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT
(Chief Financial Officer) |
S | Common Stock | D | 14100 | $150.38 - $150.38 | $2,120,346 |
| 2024-08-13 | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT
(Chief Financial Officer) |
M | Common Stock | A | 14100 | $73.60 - $73.60 | $1,037,759 |
| 2024-08-13 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
S | Common Stock | D | 7143 | $150.08 - $150.13 | $1,072,180 |
| 2024-08-13 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
M | Common Stock | A | 3043 | $103.52 - $103.52 | $315,011 |
| 2024-08-06 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
S | Common Stock | D | 273 | $147.70 - $147.70 | $40,322 |
| 2024-08-06 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
M | Common Stock | A | 273 | $79.02 - $79.02 | $21,572 |
| 2024-08-01 | NEUROCRINE BIOSCIENCES INC | Cooke Julie
(Chief Human Resources Officer) |
S | Common Stock | D | 12632 | $153.26 - $153.26 | $1,936,016 |
| 2024-08-01 | NEUROCRINE BIOSCIENCES INC | Cooke Julie
(Chief Human Resources Officer) |
M | Common Stock | A | 12632 | $61.82 - $61.82 | $780,910 |
| 2024-08-01 | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin
(Chief Legal Officer) |
S | Common Stock | D | 2996 | $154.01 - $154.01 | $461,422 |
| 2024-08-01 | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin
(Chief Legal Officer) |
M | Common Stock | A | 2996 | $79.02 - $79.02 | $236,743 |
| 2024-07-16 | NEUROCRINE BIOSCIENCES INC | Cooke Julie
(Chief Human Resources Officer) |
S | Common Stock | D | 900 | $150.04 - $150.04 | $135,036 |
| 2024-07-16 | NEUROCRINE BIOSCIENCES INC | Cooke Julie
(Chief Human Resources Officer) |
M | Common Stock | A | 900 | $61.82 - $61.82 | $55,638 |
| 2024-07-16 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
S | Common Stock | D | 2857 | $150.00 - $150.10 | $428,627 |
| 2024-07-16 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
M | Common Stock | A | 1957 | $103.52 - $103.52 | $202,588 |
| 2024-07-16 | NEUROCRINE BIOSCIENCES INC | LYONS GARY A
(Director) |
S | Common Stock | D | 930 | $150.03 - $150.03 | $139,530 |
| 2024-07-16 | NEUROCRINE BIOSCIENCES INC | LYONS GARY A
(Director) |
M | Common Stock | A | 930 | $42.76 - $42.76 | $39,766 |
| 2024-07-16 | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT
(Chief Financial Officer) |
S | Common Stock | D | 900 | $150.04 - $150.04 | $135,036 |
| 2024-07-16 | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT
(Chief Financial Officer) |
M | Common Stock | A | 900 | $73.60 - $73.60 | $66,240 |
| 2024-07-16 | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin
(Chief Legal Officer) |
S | Common Stock | D | 7004 | $150.00 - $150.00 | $1,050,590 |
| 2024-07-16 | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin
(Chief Legal Officer) |
M | Common Stock | A | 7004 | $79.02 - $79.02 | $553,456 |
| 2024-07-01 | NEUROCRINE BIOSCIENCES INC | Cooke Julie
(Chief Human Resources Officer) |
S | Common Stock | D | 10000 | $140.19 - $140.19 | $1,401,864 |
| 2024-07-01 | NEUROCRINE BIOSCIENCES INC | Cooke Julie
(Chief Human Resources Officer) |
M | Common Stock | A | 10000 | $61.82 - $61.82 | $618,200 |
| 2024-07-01 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
S | Common Stock | D | 272 | $138.11 - $138.11 | $37,565 |
| 2024-07-01 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
M | Common Stock | A | 272 | $79.02 - $79.02 | $21,493 |
| 2024-05-29 | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A
(Director) |
S | Common Stock | D | 40000 | $133.46 - $133.47 | $5,338,564 |
| 2024-05-29 | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A
(Director) |
M | Common Stock | A | 40000 | $42.76 - $47.89 | $1,787,350 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |